Application 022066

Type
NDA
Sponsor
GE HEALTHCARE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001OMNISCANGADODIAMIDEINJECTABLE;INJECTION14.35GM/50ML (287MG/ML)NoNo
002OMNISCANGADODIAMIDEINJECTABLE;INJECTION28.7GM/100ML (287MG/ML)YesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0407-0690OMNISCANgadodiamideGE Healthcare Inc.NDACurrent
0407-0690OMNISCANgadodiamideGE Healthcare Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
81485SUPPL 2025-03-07
81484SUPPL 2025-03-07
81447SUPPL 2025-03-06
79423SUPPL 2024-08-16
79200SUPPL 2024-07-24
79176SUPPL 2024-07-24
77353SUPPL 2024-01-29
77328SUPPL 2024-01-29
60664SUPPL2019-10-24
60656SUPPL2019-10-24
56334SUPPL2018-11-08
56304SUPPL2018-11-06
53893SUPPL2018-05-01
53859SUPPL2018-04-27
53858SUPPL2018-04-27
16879SUPPL2014-11-20
6809SUPPL2014-11-18
6807SUPPL2013-08-29
16878SUPPL2013-08-28
6808SUPPL2012-12-13
29187SUPPL2010-12-22
16877SUPPL2010-12-20
44672ORIG2008-10-03
21923ORIG2008-10-03
23696ORIG2007-09-24
16876ORIG2007-09-07
6806ORIG2007-09-07